Sarepta Therapeutics, Inc. - Feb 7, 2025 Form SCHEDULE 13D Schedule Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Filing Manager: Sarepta Therapeutics, Inc.
Reporting Manager: Sarepta Therapeutics, Inc.
Security: ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock")
Symbol: ARWR
Shares outstanding: 126M shares
Disclosed Ownership: 11.9M shares
Ownership: 9.5%
Form type: SCHEDULE 13D
Date filed: 2/14/2025, 05:23 PM
Date of event: Feb 7, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Sarepta Therapeutics, Inc.	9.5%	11.9M	0	11.9M	/s/ Ian Estepan	Ian Estepan, Executive Vice President, Chief Financial Officer	0000873303
Sarepta Therapeutics Investments, Inc.	9.5%	11.9M	0	11.9M	/s/ Joe Bratica	Joe Bratica, President